FBRX common stock will be immediately removed from Nasdaq and deregistered. Holders should expect zero trading liquidity on the exchange and likely a move to OTC markets or complete extinguishment of equity value. The 'matured, redeemed, or retired' designation suggests the securities may have been called or cancelled — any remaining equity value is likely zero. Do not hold through the delisting.
Price Chart
Executive Summary
Nasdaq filed a Form 25-NSE with the SEC on August 27, 2026, to remove Forte Biosciences (FBRX) common stock from listing and deregister the security under Section 12(b) of the Exchange Act. The delisting is effective immediately, citing Rule 17 CFR 240.12d2-2(a)(3), which covers matured, redeemed, or retired securities. This is a terminal event for the publicly traded equity — the stock will cease trading on Nasdaq and the company's SEC reporting obligations under Section 12(b) will terminate.
Key Facts
- Nasdaq filed Form 25-NSE to delist Forte Biosciences common stock effective August 27, 2026.
- The delisting is under Rule 17 CFR 240.12d2-2(a)(3) for matured, redeemed, or retired securities.
- The filing was made by Nasdaq Stock Market LLC (filer) with Forte Biosciences as the subject company.
- The company's SEC file number is 001-38052 and the security is Common Stock.
- The delisting terminates the company's Section 12(b) registration and associated reporting obligations.
Financial Impact
Complete loss of public listing and trading liquidity for FBRX common stock. No financial figures available in the filing.
Risk Factors
- Complete loss of trading liquidity on Nasdaq
- Potential total loss of equity value if securities were redeemed or retired
- No further SEC reporting obligations — reduced transparency for any remaining over-the-counter trading
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (FBRX) — Batch item 1 | 0001354457-26-000824 |
| Document: 0001354457-26-000824-index-headers.html | 0001354457-26-000824 |
| Document: 0001354457-26-000824-index.html | 0001354457-26-000824 |
| Document: 0001354457-26-000824.txt | 0001354457-26-000824 |
| 25-NSE Filing (FBRX) — Batch item 5 | 0001354457-26-000824 |
| Document: 0001354457-26-000824-index-headers.html | 0001354457-26-000824 |
| Document: 0001354457-26-000824-index.html | 0001354457-26-000824 |
| Document: 0001354457-26-000824.txt | 0001354457-26-000824 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | EFFECT | $76.99 awaiting T+1 | awaiting T+1 | — | — |
Sep 2, 2026 4w ago | EFFECT | $76.99 awaiting T+1 | awaiting T+1 | — | — |
Aug 27, 2026 5w ago | 25-NSE | $76.99 $76.99 | · 0.00% | ▼ −0.23% | — |
Jul 27, 2026 9w ago | 8-K | $76.50 $76.65 | ▲ +0.20% | ▼ −0.04% | — |
Jun 11, 2026 16w ago | EFFECT | $17.40 $17.56 | ▼ −0.92% | ▼ −0.38% | — |
Jun 6, 2026 16w ago | S-3/A | $15.67 $17.00 | ▼ −8.49% | ▼ −8.78% | — |
Jun 2, 2026 17w ago | S-3 | $17.00 $16.69 | ▲ +1.82% | ▲ +2.22% | — |
Jun 2, 2026 17w ago | 8-K | $17.00 $16.69 | ▼ −1.82% | ▼ −2.23% | — |
May 14, 2026 20w ago | 8-K | $23.11 $20.97 | ▼ −9.26% | ▼ −9.20% | — |
Apr 9, 2026 25w ago | 8-K | $33.90 $35.09 | ▲ +3.51% | ▲ +3.57% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access